Application of propensity scores to explore the effect of public reporting of medicine use information on rational drug use in China: a quasi-experimental design

BMC Health Services Research

Xinping Zhang¹  Lijun Wang¹  Xiaopeng Zhang¹ 

[1] School of Medicine and Health Management, Tongji Medical College, HuaZhong University of Science and Technology, Wuhan, Hubei Province, China

关键词: China;    Rational drug use;    Transparency;    Township hospitals;    Propensity score;    Quasi-experimental design;   

Others  :  1092174
DOI  :  10.1186/s12913-014-0492-6

 received in 2014-05-29, accepted in 2014-10-06,  发布年份 2014

【 摘 要 】

Background

Transparency has become a hottest topic and a growing movement in the health care system worldwide. This study used a quasi-experimental design method to explore whether public reporting of medicine use information can improve rational drug use.

Methods

20 township hospitals and 274 doctors of City Y in Hubei Province, China were divided into the intervention and control groups on the basis of their characteristics. In the intervention group, the values and rankings of the average expenditure per prescription, percentage of prescriptions requiring antibiotics and percentage of prescriptions requiring injections of each hospital and doctor were publicly released to patients and doctors in an appropriate format monthly. Data were gathered both four months before and after the intervention. Propensity score matching (PSM) was used to minimize the observed covariate (gender, age, experience, education level, title, and monthly income) differences in the doctors’ characteristics. 108 pairs of doctors were obtained after PSM. Chi-square test and t-test were employed to explore the effect of public reporting of medicine use information on rational drug use. The study was approved by the Committee of Tongji Medical College, Hua Zhong University of Science and Technology (IORG No: IORG0003571).

Results

In baseline, the average expenditure per prescription of the 274 doctors was 42.82 RMB yuan (USD 6.97), the percentage of prescriptions requiring antibiotics was 63.00%, and the percentage of prescriptions requiring injections was 70.79%, all higher than the average of Hubei Province and the standard recommended by WHO. Before the intervention all the three indicators were all comparable (p > 0.05), whereas after the intervention, a significant difference (p < 0.05) was found for the percentage of prescriptions requiring injections between the intervention (64.66%) and control groups (70.52%).

Conclusions

Irrational drug use remains a policy issue in township hospitals in the study area. We demonstrated that publicly reporting medicine use information could decrease the percentage of prescriptions requiring injections in township hospitals in China, but this effect was not observed on prescription costs and antibiotics use. Analyses of the mechanism and long-term effect of public reporting of medicine use information are recommended for further studies.

【 授权许可】

   
2014 Zhang et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Crossing the Quality Chasm: A New Health System for the Twenty-First Century. National Academies Press, Washington; 2001.
• [2]Collins SR, Davis K: Transparency in Health Care: The Time Has Come. The Commonwealth Fund; 2006.
• [3]Colmers J: Public Reporting and Transparency. The Commonwealth Fund. January 2007.
• [4]Berwick DM, James B, Coye MJ: Connections between quality measurement and improvement. Med Care 2003, 41:130-138.
• [5]Fung CH, Lim YW, Mattke S, Damberg C, Shekelle PG: Systematic review: the evidence that publishing patient care performance data improves quality of care. Ann Intern Med 2008, 148(2):111-123.
• [6]Marshall MN, Shekelle PG, Davies HT, Smith PC: Public reporting on quality in the United States and the United Kingdom. Health Aff 2003, 22(3):134-148.
• [7]Jung K: The impact of information disclosure on quality of care in HMO markets. Int J Qual Health Care 2010, 22(6):461-468.
• [8][http://www.hira.or.kr/eng/news/02/1212222_25619.html] webcite Health Insurance Review & Assessment Service: Comprehensive Quality Report of National Health Insurance 2010. Seoul: 2010 [].
• [9]Chaudhry M, Gauld R, Horsburgh S: Hospital quality-of-care performance measurement and reporting: what New Zealand can learn from the United States and United Kingdom. N Z Med J 2012, 125(1366):51-63.
• [10]Jang WM, Eun SJ, Lee CE, Kim Y: Effect of repeated public releases on cesarean section rates. J Prev Med Public Health 2011, 44(1):2-8.
• [11]Bundorf K, Choudhry K, Baker L: Health plan performance measurement: does it affect quality of care for medicare managed care enrollees? Inquiry 2008, 45:168-183.
• [12]Werner RM, Konetzka RT, Kruse GB: Impact of public reporting on unreported quality of care. Health Serv Res 2009, 44(2 Pt 1):379-398.
• [13]Hibbard JH, Stockard J, Tusler M: Does publicizing hospital performance stimulate quality improvement efforts? Health Aff 2003, 22(2):84-94.
• [14]Austin PC: Some methods of propensity score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations. Biomet J 2009, 51:171-184.
• [15]Yang L, Liu C, Ferrier JA, Zhou W, Zhang X: The impact of the National Essential Medicines policy on prescribing behaviours in primary care facilities in Hubei province of China. Health Policy Plan 2013, 28(7):750-760.
• [16][http://archives.who.int/icium/icium1997/posters/1a2_txt.html] webcite Isah AO, Ross-Degnan D, Quick J, Laing R, Mabadeje AFB: The Development of Standard Values for the Who Drug Use Prescribing Indicators. WHO; 2008 [].
• [17][http://www.who.int/entity/medicines/publications/WHOTCM2006.2A.pdf] webcite WHO: Using indicators to measure country pharmaceutical situations: fact book on WHO Level I and Level II monitoring indicators. Geneva: WHO; 2006 [].
• [18]Khang YH, Yun SC, Jo MW, Lee MS, Lee SI: Public release of Institutional Cesarean section rates in South Korea: which women were aware of the information? Health Policy 2008, 86(1):10-16.
• [19]Marshall MN, Shekelle PG, Leatherman S, Brook RH: The public release of performance data: what do we expect to gain? A review of the evidence. JAMA 2000, 283(14):1866-1874.
• [20]Schneider EC, Epstein AM: Influence of cardiac-surgery performance reports on referral practices and access to care. A survey of cardiovascular specialists. N Engl J Med 1996, 335(4):251-256.
• [21]Schneider EC, Epstein AM: Use of public performance reports: a survey of patients undergoing cardiac surgery. JAMA 1998, 279:1638-1642.
• [22]Hibbard JH, Harris-Kojetin L, Mullin P, Lubalin J, Garfinkel S: Increasing the impact of health plan report cards by addressing consumers’ concerns. Health Aff 2000, 19(5):138-143.
• [23]Hibbard JH, Slovic P, Peters E, Finucane ML: Strategies for reporting health plan performance information to consumers: evidence from controlled studies. Health Serv Res 2002, 37(2):291-313.
• [24]Clough JD, Engler D, Snow R, Canuto PE: Lack of relationship between the Cleveland Health Quality Choice project and decreased inpatient mortality in Cleveland. Am J Med Qual 2002, 17(2):47-55.
• [25]Mukamel DB, Weimer DL, Spector WD, Ladd H, Zinn JS: Publication of quality report cards and trends in reported quality measures in nursing homes. Health Serv Res 2008, 43(4):1244-1262.
• [26]Werner RM, Konetzka RT, Stuart EA, Norton EC, Polsky D, Park J: Impact of public reporting on quality of postacute care. Health Serv Res 2009, 44(4):1169-1187.
• [27]Tang Y, Zhang X, Yang C, Yang L, Wang H, Zhang X: Application of propensity scores to estimate the association between government subsidy and injection use in primary health care institutions in China. BMC Health Serv Res 2013, 13:183. BioMed Central Full Text